NFKB1 and neoplasm: The nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway is one of the key regulators of the TME, modulating the production of pro-inflammatory cytokines, chemokines, and other mediators by various cell types like tumor cells, stromal cells, and immune cells [77].